PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns.

Get the weekly brief →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago22831 SIGNALS10 FEEDS1813 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
301 Opportunity dossier O-4129 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 2 sources · 2 payment 12-week activity Recency 2026-10-30 302 Opportunity dossier O-6820 Recurring need documented in 7 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated7 items · 1 source 12-week activity Recency 2026-10-30 303 Oura Data Export and Apple Health Sync Without a Subscription Help Oura ring users access local data or sync it with Apple Health and other platforms without maintaining a paid subscription. Evidence levelCorroborated4 items · 2 sources · 1 payment 12-week activity Recency 2026-10-30 304 Opportunity dossier O-4311 Recurring need documented in 4 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated4 items · 2 sources 12-week activity Recency 2026-10-30 305 Opportunity dossier O-12221 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 306 Opportunity dossier O-12178 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 307 Opportunity dossier O-10895 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 308 Opportunity dossier O-9955 Recurring need documented in 2 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelSignal2 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 309 AI Subscription Quota Cut Alerts and Appeals Assistant Helps AI subscription users detect sudden usage-limit reductions, preserve a history of their normal allowance, file appeals, and consider moving to other tools. Evidence levelPayment-backed6 items · 2 sources · 1 payment 12-week activity Recency 2026-10-30 310 Opportunity dossier O-6241 Recurring need documented in 5 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated5 items · 1 source · 2 payment 12-week activity Recency Fading · 2026-10-30 311 Opportunity dossier O-11227 Recurring need documented in 12 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated12 items · 1 source 12-week activity Recency 2026-10-30 312 Opportunity dossier O-10374 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source 12-week activity Recency 2026-10-30 313 Opportunity dossier O-10006 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 314 Opportunity dossier O-9093 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source 12-week activity Recency 2026-10-30 315 Opportunity dossier O-8792 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source 12-week activity Recency 2026-10-30 316 Opportunity dossier O-7585 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 317 Opportunity dossier O-6320 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 2 sources 12-week activity Recency 2026-10-30 318 Opportunity dossier O-5564 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 319 Opportunity dossier O-5284 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source · 1 payment 12-week activity Recency 2026-10-30 320 Opportunity dossier O-5272 Recurring need documented in 3 independent public source items. English editorial summary pending; source evidence remains available. Evidence levelCorroborated3 items · 1 source 12-week activity Recency 2026-10-30

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.